Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Oncologia | EligiMed
Ensayos clinicos
1.365 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
LUX-Breast 1; An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
INTERVENTIONAL
Inicio: 22 de jun de 2010
ID: NCT01125566
Completado
ClinicalTrials.gov
Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HORMONE RECEPTOR POSITIVE/ HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HR+/HER2-) Advanced/Metastatic Breast Cancer In Real World Settings
OBSERVATIONAL
Inicio: 15 de may de 2019
ID: NCT05155566
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Phase III Study Comparing Biosimilar Rituximab (RTXM83) Plus CHOP Chemotherapy Versus a Reference Rituximab Plus CHOP (R-CHOP) in Patients With Diffuse Large B-cell Lymphoma (DLBCL) Given as First Line
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT02268045
Completado
Fase 3
ClinicalTrials.gov
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01479283
Desconocido
ClinicalTrials.gov
Prospective Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase Who Achieved Deep Molecular Response With Tyrosine Kinase Inhibitors in Real Life Setting in Argentina - (Argentine Stop Trial)
INTERVENTIONAL
Inicio: 1 de feb de 2019
ID: NCT05926128
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
INTERVENTIONAL
Inicio: 26 de oct de 2020
ID: NCT04475939
Completado
Fase 3
ClinicalTrials.gov
A Randomized Phase 3 Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00415194
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination With Pembrolizumab Versus Chemotherapy in Subjects With Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma That Expresses HER2 (IHC 1+ and Greater)
INTERVENTIONAL
Inicio: 22 de sept de 2023
ID: NCT05911295
Completado
Fase 3
ClinicalTrials.gov
A Phase III Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Docetaxel in Subjects With Non-Small Cell Lung Cancer That Has Progressed After a Platinum-Containing Doublet
INTERVENTIONAL
Inicio: 24 de mar de 2015
ID: NCT02395172
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Study of BMS-986416 Alone and in Combination With Nivolumab in Select Solid Tumors
INTERVENTIONAL
Inicio: 9 de ago de 2021
ID: NCT04943900
Terminado
Fase 3
ClinicalTrials.gov
A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00574275
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Phase 3, Open Label Study Evaluating Subcutaneous Versus Intravenous Administration of Isatuximab in Combination With Pomalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
INTERVENTIONAL
Inicio: 23 de jun de 2022
ID: NCT05405166
Completado
Fase 2
ClinicalTrials.gov
An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy With 400 mg Imatinib
INTERVENTIONAL
Inicio: 12 de sept de 2012
ID: NCT01593254
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
INTERVENTIONAL
Inicio: 1 de ene de 2023
ID: NCT05678673
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy
INTERVENTIONAL
Inicio: 30 de nov de 2010
ID: NCT01235962
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Phase III Study of Neoadjuvant-Adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable Gastric and Gastroesophageal Junction Cancer (GC/GEJC)
INTERVENTIONAL
Inicio: 17 de nov de 2020
ID: NCT04592913
Completado
Fase 2
ClinicalTrials.gov
An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
INTERVENTIONAL
Inicio: 1 de oct de 2009
ID: NCT00903175
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
INTERVENTIONAL
Inicio: 11 de jun de 2015
ID: NCT02414139
Desconocido
ClinicalTrials.gov
Phase 2 Study to Evaluate the Efficacy and Safety of ECOHAIR Hair Lotion in the Accelerated Recovery of Chemotherapy-induced Alopecia.
INTERVENTIONAL
Inicio: 6 de jun de 2022
ID: NCT06020586
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00076388
Anterior
1
...
67
68
69
Siguiente
Filtros